Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta Sells 22,699 Shares

Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta sold 22,699 shares of the firm’s stock in a transaction on Wednesday, July 24th. The shares were sold at an average price of $8.66, for a total transaction of $196,573.34. Following the sale, the chief operating officer now directly owns 150,569 shares of the company’s stock, valued at $1,303,927.54. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Amit Gupta also recently made the following trade(s):

• On Tuesday, July 2nd, Amit Gupta sold 7,507 shares of Cardlytics stock. The stock was sold at an average price of $7.95, for a total transaction of $59,680.65.

Cardlytics Price Performance

Shares of CDLX traded down $0.77 during mid-day trading on Wednesday, hitting $8.38. The company’s stock had a trading volume of 503,742 shares, compared to its average volume of 1,275,361. The firm has a 50-day moving average price of $8.63 and a 200 day moving average price of $9.52. The stock has a market capitalization of $408.78 million, a price-to-earnings ratio of -1.90 and a beta of 1.65. The company has a debt-to-equity ratio of 1.30, a current ratio of 2.13 and a quick ratio of 2.13. Cardlytics, Inc. has a fifty-two week low of $5.71 and a fifty-two week high of $20.52.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Wednesday, May 8th. The company reported ($0.35) earnings per share (EPS) for the quarter. The business had revenue of $67.61 million during the quarter. Cardlytics had a negative return on equity of 25.36% and a negative net margin of 55.23%. On average, research analysts predict that Cardlytics, Inc. will post -1.8 EPS for the current fiscal year.

Analysts Set New Price Targets

CDLX has been the subject of several recent analyst reports. Northland Capmk raised shares of Cardlytics to a “strong-buy” rating in a report on Tuesday, June 18th. Needham & Company LLC reissued a “buy” rating and set a $12.00 price objective on shares of Cardlytics in a report on Tuesday, June 11th. Bank of America reissued a “neutral” rating and set a $11.00 price objective on shares of Cardlytics in a report on Thursday, June 20th. Craig Hallum decreased their price target on shares of Cardlytics from $18.00 to $12.00 and set a “buy” rating for the company in a report on Thursday, May 9th. Finally, Northland Securities started coverage on shares of Cardlytics in a report on Tuesday, June 18th. They issued an “outperform” rating and a $14.00 price target for the company. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $12.67.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Cardlytics by 13.0% in the third quarter. Vanguard Group Inc. now owns 2,011,705 shares of the company’s stock worth $33,193,000 after acquiring an additional 231,303 shares in the last quarter. General Equity Holdings LP increased its position in shares of Cardlytics by 31.0% in the fourth quarter. General Equity Holdings LP now owns 624,058 shares of the company’s stock worth $5,748,000 after acquiring an additional 147,843 shares in the last quarter. Clear Street Markets LLC purchased a new position in shares of Cardlytics in the fourth quarter worth approximately $199,000. Virtu Financial LLC purchased a new position in shares of Cardlytics in the fourth quarter worth approximately $219,000. Finally, Susquehanna Fundamental Investments LLC increased its position in shares of Cardlytics by 13.8% in the first quarter. Susquehanna Fundamental Investments LLC now owns 31,536 shares of the company’s stock worth $457,000 after acquiring an additional 3,836 shares in the last quarter. 68.10% of the stock is owned by hedge funds and other institutional investors.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.